Abdukahal, Diana A.

HRN: 23-58-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
CEFOTAXIME 500MG (VIAL)
08/22/2023
08/28/2023
IV
170mg
Q8h
Meningitis
Waiting Final Action 
08/22/2023
AMPICILLIN 1GM (VIAL)
08/22/2023
08/28/2023
IV
250mg
Q8h
Meningitis
Waiting Final Action 
08/28/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/28/2023
09/03/2023
IV
150mg
Q8
Sepsis
Waiting Final Action 
08/28/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/28/2023
09/03/2023
IV
250mg
Q8
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: